Between the Biotech Waves
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
Between the Biotech Waves
Episode 13: A Between the Biotech Waves Conversation with Vic Myer, President and CSO at Chroma Medicine
•
Nessan Bermingham PhD
•
Season 1
•
Episode 13
Today we talk to Vic Myer, xChief Technology Officer at Editas, currently President and CSO at Chroma Medicine. We discuss the state of genome editing and the potential for chromatin modification.
